Aehr Test Systems AEHR
- Market cap
- $1.8B
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 36.1×
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $50M
- −15% on a year ago
- Net margin
- −14.3%
- Free cash flow yield
- −0.3%
Aehr Test Systems trades at 36.1× sales. Its trailing earnings are negative, so it has no PE. Revenue was $50M over the last twelve months, down 15% on a year earlier with a −14% net margin.
Charts
Financials
| Income statement | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $20.6M+93% | $21.4M+45% | $7.6M−56% | $16.6M−26% | $13.1M−36% | $13.5M−37% | $18.3M+142% | $14.1M−15% | $11M−16% | $9.9M−27% | $10.3M−44% | $18.8M+34% | |
| Cost of revenue | $10.6M+72% | $10.5M+52% | $4.4M−47% | $8.2M−24% | $6M−43% | $8.1M−23% | $11.1M+152% | $9.8M+20% | $7.3M+20% | $7.3M−9% | $6.9M−38% | $10.8M+10% |
| Gross profit | $10M+123% | $11M+39% | $3.2M−64% | $8.4M−26% | $7.1M−29% | $5.4M−51% | $7.2M+128% | $4.3M−49% | $3.7M−48% | $2.5M−53% | $3.4M−53% | $8M+88% |
| R&D | $2.5M+64% | $2M+27% | $2.1M+17% | $2.2M−5% | $2.4M−4% | $2.3M+15% | $3.1M+47% | $2.7M+25% | $2.8M+21% | $3M+31% | $3.2M+1% | $3.6M+36% |
| SG&A | $3.4M+35% | $3.5M+22% | $3.1M−6% | $3.8M+5% | $4.6M+34% | $4.6M+32% | $5.2M+69% | $3.9M+5% | $4.7M+4% | $4.4M−4% | $4.4M−14% | $5.6M+42% |
| $4.1M+799% | $5.5M+57% | −$2M | $2.5M−55% | $159K−96% | −$1.5M | −$1.1M−45% | −$3.2M | −$4.1M | −$4.6M+207% | −$4.2M+278% | −$1.2M−62% | |
| Interest expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pre-tax income | $4.7M+678% | $6.1M+63% | −$1.5M | $3.1M−49% | $814K−83% | −$1.2M | −$874K−40% | −$3M | −$2.8M | −$4.4M+257% | −$4M+358% | −$455K−85% |
| $16K+14% | $20K+11% | $7K−59% | −$20.7M | $154K+863% | −$217K | −$231K | −$87K−100% | −$752K | −$1.2M+459% | −$798K+246% | −$1.8M+2022% | |
| Net income | $4.7M+694% | $6.1M+64% | −$1.5M | $23.9M+291% | $660K−86% | −$1M | −$643K−56% | −$2.9M | −$2.1M | −$3.2M+214% | −$3.2M+398% | $1.4M |
| $0.16+700% | $0.20+54% | −$0.05 | $0.81+286% | $0.02−88% | −$0.03 | −$0.02−60% | −$0.10 | −$0.07 | −$0.11+267% | −$0.10+400% | $0.04 | |
| 29.6M+3% | 29.8M+2% | 28.9M−2% | 29.5M−1% | 29.6M+0% | 29.7M−0% | 29.7M+3% | 29.8M+1% | 29.9M+1% | 30.2M+2% | 30.7M+3% | 31.9M+7% |
EPS, diluted: 7 periods, Q4 FY11 to Q4 FY26: quarter's net income to common over its shares, to the cent.
Diluted shares: 9 periods, Q4 FY11 to Q4 FY26: share-days: the 12-month average less the 9-month, weighted by days. 7 periods, Q4 FY12 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Hardware, Equipment & Parts nearest Aehr Test Systems' size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| AEHRAehr Test Systems | $1.8B | n/m | 43.8× | 36.1× | −15% | −14.3% | |
| CTSCTS | $1.5B | 22.3× | 25.9× | 2.7× | +9% | 12.4% | |
| ALNTAllient | $1.5B | 51.6× | 36.0× | 2.6× | +11% | 5.0% | |
| BHEBenchmark Electronics | $2.4B | 44.8× | 24.3× | 0.8× | +9% | 1.9% | |
| ITRIItron | $3.8B | 14.6× | 42.6× | 1.7× | −6% | 11.9% | |
| OLEDUniversal Display | $4B | 21.1× | 44.6× | 6.6× | −8% | 32.2% | |
| BDCBelden | $4.1B | 16.9× | 22.7× | 1.4× | +9% | 8.5% | |
| VSHVishay Intertechnology | $4.1B | 141× | 13.2× | 1.2× | +13% | 0.9% | |
| VREXVarex Imaging | $775.5M | 35.4× | 32.1× | 0.9× | +5% | 2.6% | |
| TRNSTranscat | $766.8M | 221× | 46.1× | 2.2× | +21% | 1.0% | |
| FEIMFrequency Electronics | $723.5M | 257× | 26.8× | 9.9× | +6% | 3.7% | |
| Peer median | $1.9B | 40.1× | 29.4× | 1.9× | +9% | 4.3% |
Investors who own it
Investors we follow who held Aehr Test Systems at the end of Jun 30, 2026, from their 13F filings.
- Polen CapitalPolen Capital0.1% of portfoliotrimmed
- Baillie GiffordBaillie Gifford0.0% of portfoliotrimmed
More on Aehr Test Systems
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Its groups
About
- Industry
- Hardware, Equipment & Parts
- Sector
- Technology
Valuation data, not investment advice. Prices as of .